On "Rise in Neonatal Abstinence Syndrome Rate Is Associated with Increase in Buprenorphine Prescription Numbers"

South Med J. 2024 Aug;117(8):510. doi: 10.14423/SMJ.0000000000001711.

Authors

Satyam K Ghodasara¹, Hyo J Yang¹, Zoltan H Nemeth¹

Affiliation

¹ Department of Surgery, Morristown Medical Center, Morristown, NJ.

PMID: 39094803
DOI: 10.14423/SMJ.0000000000001711

No abstract available

Publication types

Letter

MeSH terms

Analgesics, Opioid / adverse effects
Analgesics, Opioid / therapeutic use
Buprenorphine* / therapeutic use
Drug Prescriptions / statistics & numerical data
Female
Humans
Infant, Newborn
Neonatal Abstinence Syndrome* / drug therapy
Neonatal Abstinence Syndrome* / epidemiology
Opiate Substitution Treatment / methods
Opioid-Related Disorders / drug therapy
Opioid-Related Disorders / epidemiology
Pregnancy
United States / epidemiology

Substances

Buprenorphine
Analgesics, Opioid